1·Ct and parathyroid hormone levels were detected by radioimmunoassay.
血清ct和甲状旁腺素采用放射免疫法检测。
2·Parathyroid hormone level is usually low in the first year but may increase above normal after the first year.
甲状旁腺激素水平低，通常在头一年可能会增加，但高于正常后的第一年。
3·The content of serum parathyroid hormone (PTH) in 15 patients with renal failure was measured by radioimmunoassay.
本实验用放射免疫双抗体法，测定了15例肾功能不全患者的血清甲状旁腺激素（PTH）含量。
4·Objective: to investigate the influence of serum parathyroid hormone level by resin adsorption to the chronic hemodialysis patients.
目的观察树脂吸附对慢肾衰维持性血液透析患者血清甲状旁腺素水平的影响。
5·Objective: To explore the kinetics of the plasma bone gla-protein (BGP) and N-parathyroid hormone (N-PTH) in patients with hemodialysis.
目的：观察血液透析患者血骨钙素(B G P)、n端甲状旁腺激素(N - P T H)的变化及其临床意义。
6·AIM: to observe the effect of intermittent parathyroid hormone (PTH) administration on bone histomorphology of relatively old ovariectomized rats.
目的：观察甲状旁腺激素(PTH)间歇注射对月龄较老的去卵巢大鼠骨组织形态计量学的影响。
7·Parathyroid hormone-related protein (PTI-IrP) is a homogenous peptide of parathyroid hormone, and both of them bind to the same membrane receptor.
甲状旁腺激素相关蛋白是与甲状旁腺激素同源的一种多肽类物质，二者结合于同一种细胞膜受体。
8·The levels of serum parathyroid hormone(PTH) and bone-specific alkaline phosphatase(BAP) were detected respectively before and after the treatment.
分别于治疗前后检测每组病例血甲状旁腺激素（PTH）、骨特异性碱性磷酸酶（BAP）；
9·It evaluated the effect of bone marrow removal from particular sites followed by daily injections of anabolic agents such as parathyroid hormone (PTH).
在每天注射组织代谢物如pth(甲状旁腺激素)后对特定点的骨髓移除效果进行评估。
10·Teriparitide, a form of naturally occurring parathyroid hormone, currently is the only FDA-approved anabolic or bone-building agent in the United States.
Teriparitide是自然形成的甲状旁腺激素，是美国目前唯一通过FDA认证用于骨代谢或骨构建的药物。